Quick Answer
Aurinia Pharmaceuticals Inc. reported Total Revenue of $283.06 million for fiscal year 2025.
Aurinia Pharmaceuticals Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $283.06M | +20.4% |
| 2024 | $235.13M | +34.0% |
| 2023 | $175.51M | +31.0% |
| 2022 | $134.03M | +193.9% |
| 2021 | $45.60M | -9.0% |
| 2020 | $50.12M | +15660.4% |
| 2019 | $318.0K | -31.3% |
| 2018 | $463.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $73.47M | +8.4% | +4.9% |
| June 30, 2025 | $70.01M | +22.4% | +12.1% |
| March 31, 2025 | $62.47M | +24.2% | -7.8% |
| September 30, 2024 | $67.77M | +24.3% | +18.5% |
| June 30, 2024 | $57.19M | +37.8% | +13.7% |
| March 31, 2024 | $50.30M | +46.2% | -7.7% |
| September 30, 2023 | $54.52M | -2.3% | +31.4% |
| June 30, 2023 | $41.49M | +47.2% | +20.6% |
- Aurinia Pharmaceuticals Inc. showed an increase of +20.4% in Total Revenue compared to the prior fiscal year.
- Over the 2018–2025 period, Aurinia Pharmaceuticals Inc.’s total revenue has grown by 61035.0% (from $463.0 thousand to $283.06 million).
- The most recent figure is from Aurinia Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: